Alemtuzumab therapy for refractory idiopathic hypereosinophilic syndrome. British journal of haematology. [Br J Haematol] Journal article

Title	Alemtuzumab therapy for refractory idiopathic hypereosinophilic syndrome.
Author(s)	Sefcick A, Sowter D, DasGupta E, Russell NH, Byrne JL
Source	Br J Haematol 2004 Feb; 124(4):558-9.
MeSH	Adult Antibodies, Monoclonal Antibodies, Neoplasm Eosinophils Female Humans Hypereosinophilic Syndrome Leukocyte Count
Language	eng
Pub Type(s)	Case Reports Letter
PubMed ID	14984510

Advertise on this site.